Please take the chance to talk to InnoSer about InfiCure Bio ABs unique NIF mouse model at the 6th NASH Congress! The NIF model spontaneously develops chronic inflammation and fibrosis, which is nicely presented in [...]

InfiCure Bio has started 2023 by signing an agreement with a new client in the US. Read the whole pressrelease here

InfiCure Bio enjoyed a traditional Swedish Christmas lunch at beautiful Brännlands Wärdshus. It is hard to find a more Christmasy atmosphere- and the recent snow and cold weather added an extra touch.  We wish you [...]

InnoSer and Inficure Bio enter partnership to increase accessibility of translational liver inflammation & fibrosis mouse model Read the entire pressrelease here!

The Umeå based life science company InfiCure Bio continues to take large steps in the global market by signing agreements with two major international companies. “The contracts with our new clients clearly show that pharmaceutical [...]

Sofia Mayans, CEO at Inficure Bio, will attend the annual Nordic Life Science Days in Malmö 28-29 September. We hope that you will meet Sofia in Malmö for fruitful discussions!